Replies to post #121681 on NanoViricides Inc. (NNVC)

[Nanotoday]

OK, how's this for relevant: The company had previously announced that they had optimized Flucide and had sent the lead candidate to BASi and were simply waiting for BASi to request more material to complete Tox.

Now they hire a lab to test for variants and efficacy to select a lead candidate.

Does this sound like progress?

[Rawnoc]

Today's announcement confirms what the "short cabal" has been warning for a long time:

The only reason for the switch to Herpescide is because Flucide was another embarrassing failure hence the need to start from scratch on any Flucide work going forward.

[arvitar]

The fact remains, in all of human history there has never been a single instance of a management team first failing for 11 years to get a single preclinical candidate IND-approved, and then suddenly accomplishing that.

There's no reason to believe that NNVC will be the first.

Indeed, given the age and unremarkable careers of its management team, there's plenty of reason to believe that NNVC won't be the first to set such historic precedent.